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Reduced FCGR3B copy number is associated with increased risk of systemic lupus erythematosus (SLE). The five FCGR2/FCGR3 genes are
arranged across two highly paralogous genomic segments on chromosome 1q23. Previous studies have suggested mechanisms for struc-
tural rearrangements at the FCGR2/FCGR3 locus and have proposed mechanisms whereby altered FCGR3B copy number predisposes to
autoimmunity, but the high degree of sequence similarity between paralogous segments has prevented precise definition of the molec-
ular events and their functional consequences. To pursue the genomic pathology associated with FCGR3B copy-number variation, we
integrated sequencing data from fosmid and bacterial artificial chromosome clones and sequence-captured DNA from FCGR3B-deleted
genomes to establish a detailed map of allelic and paralogous sequence variation across the FCGR2/FCGR3 locus. This analysis identified
two highly paralogous 24.5 kb blocks within the FCGR2C/FCGR3B/FCGR2B locus that are devoid of nonpolymorphic paralogous
sequence variations and that define the limits of the genomic regions in which nonallelic homologous recombination leads to
FCGR2C/FCGR3B copy-number variation. Further, the data showed evidence of swapping of haplotype blocks between these highly pa-
ralogous blocks that most likely arose from sequential ancestral recombination events across the region. Functionally, we found by flow
cytometry, immunoblotting and cDNA sequencing that individuals with FCGR3B-deleted alleles show ectopic presence of FcgRIIb on
natural killer (NK) cells. We conclude that FCGR3B deletion juxtaposes the 50-regulatory sequences of FCGR2Cwith the coding sequence
of FCGR2B, creating a chimeric gene that results in an ectopic accumulation of FcgRIIb on NK cells and provides an explanation for SLE
risk associated with reduced FCGR3B gene copy number.Introduction
Systemic lupus erythematosus (SLE [MIM 152700]) is
a chronic autoimmune disease with effects on many organ
systems including skin, lungs, heart, joints, blood, and
kidneys. Environmental triggers and genetic factors
predispose to development of SLE, but the molecular
mechanisms are not well understood.1 However, impaired
clearance of immune complexes and dying cells, dysregu-
lation of apoptosis, and presence of autoantibodies to
nuclear antigens are believed to be involved.2 There is
increased prevalence of disease in non-European popula-
tions and women are at ~10-fold greater risk than men.3
The FCGR locus on chromosome 1q23 is subject to copy-
number variation (CNV) with reduced copy number of
FCGR3B associating with the immune diseases SLE and
rheumatoid arthritis (RA [MIM 180300]) in various popula-
tions.4–9 Besides FCGR3B (CD16B [MIM 610665]), the
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[MIM 146740]), FCGR2C (CD32C [MIM 612169]), and
FCGR2B (CD32B [MIM 604590]), encoding respectively
the proteins for FcgRIIa, FcgRIIIa, FcgRIIc, and FcgRIIb.
FcgRIIa and FcgRIIc contain immunoreceptor tyrosine-
based activatory motifs (ITAMs); FcgRIIIa, like the high
affinity activatory FcgRI, signals through a common
gamma chain, and FcgRIIIb ismembrane-linked by a glyco-
sylphosphatidylinositol (GPI) anchor. These are all activa-
tory receptors unlike FcgRIIb (encoded by FCGR2B), which
contains an immunoreceptor tyrosine-based inhibitory
motif (ITIM).10 The five FCGR genes are arranged across
two ~85 kb paralogous blocks suggesting an evolutionary
origin through tandem duplication (Figure 1A). The
centromeric (proximal) block contains FCGR2A, FCGR3A,
and the 50 portion of FCGR2C. The telomeric (distal) block
contains the 30 portion of FCGR2C as well as FCGR3B and
FCGR2B.11 Paralog ratio test (PRT) and multiplex ligation-
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Figure 1. Copy-Number Variation at the FCGR Locus
(A) Arrangement of FCGR genes across the FCGR2/FCGR3 cluster on chromosome one. Black bars below the gene loci indicate proximal
and distal regions of paralogy.
(B) CGH array data showing the deletion of FCGR3B and surrounding area. Probe design based on NCBI assembly version 35 (hg17).
(C) Pulsed field gel electrophoresis and Southern blotting with FCGR2 and FCGR3 probes of PmeI digested genomic DNA from individ-
uals with different FCRGR3B copy number. Copy number refers to the number of FCGR3B containing haplotyptes. In two-copy individ-
uals with FCGR3B present on both chromosomes, a band of size 267 kb is detected representing the FCGR3B containing haplotype. The
presence of a smaller-size band (182 kb) in individuals with one or both copies of FCGR3B missing, which is not detected in two-copy
individuals, indicates the loss of an ~85 kb region of genomic DNA on FCGR3B-deleted haplotypes.stable Mendelian inheritance of CNV blocks containing
FCGR3A, FCGR2C, and FCGR3B but have not shown
CNV at the FCGR2A and FCGR2B loci.7,12 The most
common CNV block includes FCGR3B and FCGR2C and
it was recently proposed that FCGR3B CNV is the result
of nonallelic homologous recombination between prox-
imal and distal FCGR paralogs.13
Previous studies have suggested mechanisms whereby
loss of either FCGR3B or FCGR2C may predispose to auto-
immunity by reducing binding and clearance of immune
complexes. FCGR3B is expressed on neutrophils and
a direct positive correlation has been observed between
the number of copies of FCGR3B and FcgRIIIb translation
and function.7,14 It has previously been suggested that
loss of FCGR3B may alter immune complex handling in
the tissues by neutrophils4,7,14 although the role of neutro-
phils in immune complex handling is not well understood.
In addition to CNV, FCGR3B exhibits several polymor-
phisms that affect function of the receptor. Single nucleo-
tide changes at five locations define the two alleles, NA1
and NA2 that produce receptors with similar affinity to
IgG1 but FcgRIIIb-NA1 has approximately double the
affinity of the NA2 allele for monomeric IgG3.15 Low
copy number of FCGR3B, in particular deletion of theThe AmNA1 allele is associated with SLE, potentially conferring
disease risk by reduced expression due to lower copy
number and by reduced binding to the receptor.7
FCGR2B, the only inhibitory Fc receptor, has a polymor-
phism in the transmembrane domain, Ile232Thr
(rs1050501), that alters activity with the 232Thr variant
having lower affinity for lipid rafts and thereby a decreased
inhibitory effect.16,17 The 232Thr variant is associated with
SLE in East Asian and European populations.18 Because
FcgRIIb is the only inhibitory FcgR, a reduction in its func-
tion could cause increased immune responsiveness and
predisposition to autoimmunity. Consistent with this,
downregulation of FCGR2B expression has been reported
in SLE.19 The known involvement of the various FcgRs
on 1q23 in SLE lends support to the hypothesis that
FCGR3BCNVmay promote autoimmunity by effects other
than, or in addition to, those arising directly from the
altered expression of the gene encoded within the area of
CNV. SLE susceptibility appears to be associated with
alleles of lower affinity (FCGR2A-131R, FCGR3A-158F) or
loss of higher affinity alleles (FCGR3B-NA1) lending
support to the clearance hypothesis.
In this study, to pursue the underlying mechanism of
SLE disease association with FCGR3B CNV, we establishederican Journal of Human Genetics 92, 28–40, January 10, 2013 29
a detailed map of allelic and paralogous sequence variation
(PSV) across the FCGR2/FCGR3 locus. We define the limits
of the breakpoint regions associated with structural varia-
tion at this locus and further show that deletion of FCGR3B
results in creation of a fusion gene with ectopic presence of
FcgRIIb on natural killer cells that provides an explanation
for SLE susceptibility encoded at this locus.Material and Methods
Fosmid Clone Sequencing and Assembly
Fosmid clones of ~40 kb human DNA fragments from eight indi-
viduals were obtained from the authors of.20 Based on the
mapping of end-sequence pairs (ESPs) to the human reference
genome (hg18) provided by the authors, haplotype-assigned fos-
mid clones21 tiling across the FCGR locus (chr1:161,400,000–
161,750,000) were selected.
Fosmid inserts were sequenced in a multiplexed sequencing run
on the 454/Roche GS FLX Titanium sequencing platform. Library
barcoding was carried out as described previously.22 Sequencing
reads were detagged and sorted by fosmid with the untag
command line tool (version 0.99.2). Quality and adapter clipped
sequences and Phred scaled quality scores were extracted to FASTA
formatted files with the sff_extract command line tool (version
2.0). Reads from each fosmid were assembled into contigs with
the Roche GS De Novo Assembler Software (version 2.5).
Fosmid End-Sequence Pair Mapping
Fosmid inserts were anchored on the GRCh37 (hg19) assembly of
the reference genome by mapping of the ESPs to the reference
sequence. To obtain ESP sequences from the NCBI trace archive,
we retrieved fosmid-clone-ID-to-NCBI-trace-name mappings
from the Human Genome Structural Variation Project website.
Trace names were mapped to TI numbers (trace IDs), and the
respective trace sequences and quality scores downloaded from
the NCBI trace archive by using a Perl script available from the
NCBI FTP site. The NCBI project ID required for the query was
29893. Trace sequences were aligned to the GRCh37 (hg19)
assembly of human chromosome 1 with the alignment tool
BLAT23 (version 3.4). The alignments were subsequently filtered
for the highest scoring hits with the pslReps tool distributed
with the BLAT software package by using the -singleHit option.
Alignments were processed to retain only concordant mappings.
SNP and Indel Calling
To identify SNPs and indels between fosmid inserts and the refer-
ence sequence, we mapped the assembled contigs to the reference
genome with the BLAST local alignment tool. SNP and indel posi-
tions were parsed from the BLAST XML output by using a custom
Perl script.
Targeted Sequencing
Genomic DNA was hybridized to custom Roche/NimbleGen
capture arrays to enrich a 550 kb region on chromosome 1
(chr1:161,325,000-161,875,000) containing the FCGR2/FCGR3
gene cluster. The array probe design was based on the NCBI 36
(hg18) assembly of the human reference genome. To account
for the segmental sequence similarity and to increase probe
coverage, we allowed nonunique probes. The captured DNA was
sequenced in a multiplexed Roche/454 GS FLX Titanium30 The American Journal of Human Genetics 92, 28–40, January 10, 2sequencing run. Ethical approval for the DNA samples was as
previously reported.7
CNV-seq Analysis
Sequencing reads were detagged and sorted by sample with the
sff_file command line tool of the SFF tools package (version 2.0)
provided by Roche/454. From the resulting SFF files sequences
and Phred scaled quality scores were extracted to FASTA formatted
files with the sff_extract command line tool (version 2.0).
Reads were mapped to the GRCh37 (hg19) assembly of the
human genome sequence with BWA.24 Reads with a length
R200 bp were mapped with BWA-SW for long reads,25 and reads
shorter than 200 bp were mapped with BWA for short reads.24
Read depth analysis to identify CNV regions from sequencing
data was carried out with the CNV-seq package.26 Read count
ratios were calculated across 1.5 kb windows. A p value of 0.05
was chosen as the significance threshold for detected CNV regions
defined as four consecutive 1.5 kb windows with a log2 ratio of
R0.69 (R1.6-fold difference in read depth).
Flow-Cytometric Analysis
The antibodies used were CD32B-Alexa488 (clone 2B6; Macrogen-
ics), CD19-PE-Cy7 (BD Pharmigen), CD56-APC (Biolegend) Cells.
Samples from volunteers were subjected to Ficoll-Hypaque density
separation to isolate PBMC. Natural killer (NK) cells were enriched
from PBMC by positive selection by using CD56 MACS beads
(Miltenyi). B cells were enriched by negative selection by using
Dynabeads Untouched Human B Cells.
Nucleic-Acid Isolation
Total RNA was isolated from 107 cells (B or NK cells) by using
TRIzol total RNA isolation reagent (Gibco BRL, Grand Island,
NY). Four hundred nanograms of total RNA were used to synthe-
size cDNA with the RevertAid First Strand cDNA Synthesis Kit
(Fermentas).
Transcript Analysis
The FCGR2B RT-PCR was performed with 1 ml cDNA, 300 nM each
primer (sense primer 50-GAGAAGGCTGTGACTGCTGT-30, anti-
sense primer 50-TACCAGATCTTCCCTCTCTG-30), 200 mM dNTPs,
1.5 mMMgCl2, and 0.5 units Platinum Taq DNA polymerase in
a 25 ml reaction volume, starting with 94C for 2 minutes, 35
cycles of denaturing at 94C for 30 seconds, annealing at 60C
for 30 seconds, extension at 72C for 1.5 minutes, with a final
extension at 72C for 10 minutes. The product was sequenced
by the Sanger method using the primer 50-CCTCACCTGGAGTTC
CAGGAGGGAG-30 to analyse the FGCR2B SNP rs1050501
(p.Ile232Thr).
Protein Immunoblot
Standard protein immunoblot analysis was performed using
FcgRIIb-specific antibody (CD32B[C-20] Santa Cruz Biotech-
nology).Results
Assessment of Size of CNV at FCGR2C/FCGR3B
PRT assay27 of ~2,500 SLE cases, unaffected relatives and
controls4,7 identified eight individuals homozygous
for loss of FCGR3B, whom we describe as zero-copy013
Figure 2. PSV and Breakpoint Analysis at the FCGR Locus
Proximal and distal regions of the reference sequence thatwere aligned to identify candidate PSVs are indicated below the FCGR gene loci.
A regionof ~1.5 kb in the centre of the FCGR2 gene loci is found in all three paralogs (2A-2C-2Bparalogous region). The locations of candi-
date PSVs, SNPs, andPSVs remaining after removal of polymorphic PSVs are shown.Nonpolymorphic PSVs are absent in a 24.5 kb interval
starting upstream of FCGR2C/FCGR2B and ending in intron five of FCGR2C/FCGR2B. The blow-ups show the SNPs and PSVs flanking the
breakpoint region. The 50 border is defined by a 449 indel PSVand three single nucleotide PSVs while the 30 border is defined by a combi-
nation of three single nucleotides with the combination CCT identifying the FCGR2C locus and the combination TCT identifying the
FCGR2B locus.individuals. Comparative genomic hybridization (CGH)
array analysis was performed on two of these zero-copy
individuals. They were arrayed against a known two-copy
control. The data indicates that the genomic region around
and including FCGR3B is absent in the zero-copy individ-
uals (Figure 1B). However, cross hybridization between
the proximal and distal probes prevents this method from
identifying the boundaries of the deletion with accuracy.
Pulsed field gel electrophoresis (PFGE) and Southern blot-
ting of PmeI digested gDNA from two of the zero-copy indi-
viduals and their heterozygous (one-copy) relatives with
FCGR2 and FCGR3 probes confirmed the loss of ~85 kb in
FCGR3B-deleted haplotypes (Figure 1C). These deletions
may not be identical in terms of the exact boundaries of
the deleted region because the PFGE Southern blot analysis
would not detect variations of <10 kb, but the analysis
demonstrates that individuals who were shown by PRT to
have zero copies (Figure 1C, lanes 5 and 6) or one copy
(Figure 1C, lanes 1 and 2) of FCGR3B aremissing a similarly
sized genomic region. Taken together with the array CGH
result, the PFGE data show the approximate size of the
area deleted (~85 kb) in zero- or one-copy individuals but
do not identify the precise boundaries of the deletion(s).
Analysis of Sequence Variation at the FCGR Locus
To identify paralogous sequence variants (PSVs) that could
be used to map the boundaries of the deleted region in our
zero-copy individuals, we aligned the reference sequence
(GRCh37/hg19) of the proximal block of the FCGR locus
(chr1:161,480,906–161,564,008) to that of the distal block
(chr1:161,562,570–161,645,839; Figure 2). Over the align-
ment length of 85.2 kb, the two blocks showed 93.7%
sequence identity. This included a 26.1 kb region of paral-
ogy in FCGR2C and FCGR2B that encompasses the 50
coding region of 12.8 kb and an upstream region ofThe Am13.3 kb, that overall showed 99.2% identity. A total of
1,202 positions showed variation between the proximal
and distal 85.2 kb blocks constituting a set of candidate
PSVs. However, PCR-based sequence analysis failed to
find any PSVs in this region that did not show allelic vari-
ation between individuals (data not shown), confounding
breakpoint analysis. To identify nonpolymorphic PSVs
that could help to identify the location of the breakpoints,
we undertook a systematic sequence analysis of the
FCGR2/FCGR3 locus in eight unrelated individuals by
high-throughput sequencing and de novo assembly of fos-
mid clones derived from the region.
A total of 156 fosmids tiling across the FCGR locus
between position 161,438,169 and 161,736,847 (see
Figure S1 available online) were sequenced on the Roche/
454 platform. The average insert size of ~40 kb, smaller
than the size of the duplicated block (~85 kb), avoided con-
founding effects caused by sequence of both regions of
high similarity being present in a single insert, which
could have resulted in chimeric assemblies of proximal
and distal sequence.
SNPs were called from alignments of assembled fosmid
insert sequences to the reference genome (GRCh37/hg19).
The alignments were guided by the anchoring of the fos-
mids on the genome sequence based on their ESPs facili-
tating assignment of assembled sequence to proximal or
distal block. A total of 1,748 SNPs were detected across the
locus. A more accurate pool of potential PSVs was then
generated by discarding those PSVs with allelic variation
in either the proximal or distal block.
Intersecting the 1,748 SNPs that were detected from the
fosmid sequencing with the 1,202 candidate PSVs identi-
fied from alignment of the reference sequence (Figure 2;
Table S1) revealed that around one third of the PSVs
(434) were subject to allelic variation in either theerican Journal of Human Genetics 92, 28–40, January 10, 2013 31
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Figure 3. Swapping of Proximal and Distal Haplotype Blocks
Comparison of SNP patterns to candidate PSVs derived from the reference sequence shows that two haplotype blocks located at the
outer boundaries of the breakpoint region (dashed boxes) appear to be swapped between proximal and distal region on a number of
chromosomes.
(A) Paralogous sequence variation within swapped haplotype blocks. PSVs were derived by global alignment of proximal and distal
region of paralogy. Only candidate PSVs within the two swapped blocks are shown with the color coding representing the PSV ‘‘allele’’
at the paralogous site.
(B) Allelic sequence variation within swapped haplotype blocks. SNPs were identified by sequencing of fosmid clones from six individ-
uals (ABC7, ABC8, ABC10, ABC12, ABC13, ABC14) and hydatidiformmole BAC clones from one individual. SNP alleles at the respective
positions are shown below for each individual (ABCx) and chromosome (A/B). Grey shading indicates missing haplotype information.
High similarity between SNP and PSV patterns suggest that sequence between the two paralogous regions has been swapped.proximal or distal segment and thus unsuitable as paralog-
specific markers, leaving 768 potentially informative PSVs.
However, nonpolymorphic PSVs were completely absent
in a 24.5 kb interval that is contained within the 26.1 kb
region of 99.2% identity defined by the reference sequence
alignment and includes the upstream region and first five
exons/introns of FCGR2C/FCGR2B (Figure 2).
Interestingly, two haplotype blocks at either end of the
24.5 kb PSV-free regions were found to have swapped
between the proximal and distal region in some of the
sequenced individuals (Figure 3). Comparison of paralo-
gous sequence variation (Figure 3A) and allelic sequence
variation (Figure 3B) showed that in some cases the pattern
of allelic variation in the proximal block was similar or
identical to the PSV pattern of the distal block, and vice
versa, suggesting that ancestral sequence exchange has
occurred between the two regions. Because the ESPs of
the fosmids that contained the swapped regions map to
sequence that is specific to either the proximal or the distal
block, incorrect anchoring to the reference could be
excluded as a cause for the observed haplotype swapping.
To exclude the possibility that structural inconsistencies
in the reference assembly as described recently for other
loci that are subject to structural variation28 could underlie
the observed phenomenon and could potentially hamper
our analyses, we sought to confirm the structural arrange-32 The American Journal of Human Genetics 92, 28–40, January 10, 2ment of the FCGR2/FCGR3 locus in the reference assembly.
Five clones from a haploid hydatidiform mole bacterial
artificial chromosome (BAC) library (Table S2) tiling across
the FCGR2/FCGR3 locus (see Figure S2) with an average
insert size of 200 kb were sequenced by capillary
sequencing. Alignment of the assembled BAC sequences
to the reference sequence confirmed the overall organiza-
tion of the locus. The only discrepancy observed was
discordance between the expected insert size of two clones
(CH17-318H14, CH17-135E1) and the region they aligned
to in the reference assembly. However, this was explained
by compression of a tandem repeat region upstream of
the FCGR2/FCGR3 cluster in the reference. This inconsis-
tency had already become evident from mapping of
sequence capture data generated across the locus (see
Figure S2), which we discuss further below. Furthermore,
the BAC clone sequencing also confirmed the haplotype
swapping we had observed in the fosmid data as clone
CH17-135E1 also contained a swapped haplotype (see
Figure 3) which explained why the 30 end of the clone
had initially been wrongly anchored at the FCGR2B locus
by ESP mapping (Figure S3).
Mapping of FCGR3B CNV Breakpoints
Of the 768 potentially informative PSVs that remained
after analysis of the fosmid sequence data, we specifically013
Table 1. Chromosomal Positions, as Annotated in the GRCh37/hg19 Assembly, of Nonpolymorphic PSVs Used to Distinguish Proximal and
Distal Sequence at the FCGR2C/FCGR2B Loci in Proximity of the FCGR3B CNV Breakpoint Region
Proximal Region Distal Region
Position PSV ‘‘allele’’ Position PSV ‘‘allele’’
161,537,464 449 bp deletion 161,618,848–161,619,296 449 bp insertion
161,537,898 A 161,619,727 G
161,537,999 T 161,619,829 A
161,538,110 T 161,619,940 C
24.5 kb interval without PSVs
{161,562,577;161,562,582;161,562,584} {C;C;T}a {161,644,408;161,644,413;161,644,415} {T;C;T}a
aPSVs flanking the 30 end of the 24.5 kb interval have to be interrogated in combination because individual PSVs do not identify FCGR2C/FCGR2B sequence unam-
biguously as a result of FCGR2A/FCGR2C/FCGR2B paralogy (see Figure 2).examined those close to the approximate breakpoint posi-
tion estimated from PFGE and CGH arrays. The selected
PSVs (Table 1) were further substantiated by Sanger
sequencing in 12 individuals with normal FCGR3B diploid
copy number (two copies, one on each chromosome) to
confirm that a proximal and distal variant (parallele) was
always present (data not shown).
The verified PSVs were used to map the region contain-
ing the breakpoint in our eight individuals homozygous
for the deleted haplotype (FCGR3B zero-copy). For each
individual, PSVs were typed by PCR and sequencing to
identify the presence of proximal or distal paralleles.
Absence of either the proximal or distal parallele was
used to map the boundaries of the absent genomic
segment containing FCGR3B. A 449 bp indel PSV plus
three single nucleotide PSVs upstream of FCGR2C/FCGR2B
mark the 50 end of the breakpoint-containing region and
a combination of three single nucleotide PSVs in intron
five of FCGR2C/FCGR2B mark the 30 boundary in all eight
of our zero-copy individuals (Figure 2; Table 1). This leaves
a ~24.5 kb region bounded by FCGR2C upstream sequence
and FCGR2B intron five in the deleted individuals within
which the breakpoint(s) must lie.
To derive further supporting data of the location of the
breakpoint, FCGR loci of two trios and two single parent
families containing FCGR3B zero-copy individuals (five
one-copy and five of our eight zero-copy individuals)
were sequenced on the Roche/454 Titanium platform.
Genomic DNA from these individuals was hybridized to
custom Roche/NimbleGen capture arrays to enrich a 550
kb region (chr1:161,325,000–161,875,000) containing
the FCGR2/FCGR3 locus and then sequenced.
Copy-number-variable regions in zero-copy offspring
were detected by read depth analysis (CNV-seq) by using
one-copy parents as control samples. Significant copy-
number variation was detected in the region containing
FCGR3B and surrounding sequence in the deleted haplo-
type individuals. This confirmed deletion of FCGR3B and
gave an indication of the extent of the deletion from the
middle of FCGR2C to immediately 50 of FCGR2B (see
Figure S4). However, the high sequence similarity betweenThe Amthe 50 regions of FCGR2C and FCGR2B resulted in cross-
mapping of sequencing reads derived from these regions.
This hampered detection of CNV from read depth in the
region upstream of FCGR2B.
Reads from these individuals were also used to verify the
449 bp indel PSV upstream of exon one and the four
PSVs located in intron five of FCGR2C and FCGR2B.
The sequencing reads from this region on 15 deleted
haplotypes (the five zero-copy individuals and their five
one-copy relatives) were searched for evidence of an unbal-
anced breakpoint, as evidenced by chimeric sequence in
which verified proximal and distal PSVs were juxtaposed
in a single read. However, our analysis failed to find a single
such chimeric sequence. Furthermore, the reads captured
from zero-copy individuals could be assembled de novo
into contigs (data not shown), which, when aligned to
the reference, like the mapping analysis, did not show
any evidence of an unbalanced breakpoint. Figure 4A
shows the organization of the FCGR locus in an FCGR3B
zero-copy individual derived from the de novo assembly
of captured reads.
By using PRT, we genotyped the eight HapMap individ-
uals, whose genome had been cloned in the fosmid
libraries, for copy-number polymorphism at FCGR3B.
Two of these individuals (libraries ABC9 and ABC11) carry
a duplicated FCGR3B haplotype. We were able to identify
fosmids from these libraries where the 50 end of the fosmid
discordantly mapped to the FCGR3B and the 30 end discor-
dantly to the FCGR2C locus of the reference assembly
(Figure S5A). Thus these fosmid inserts must contain the
duplication breakpoint, which is likely to be similar to
the deletion breakpoint. No hybrid reads from these
fosmids were found, confirming that the duplication
breakpoint also lies in a region of high similarity between
proximal and distal region. Figure 4B shows the organiza-
tion of the FCGR locus on a haplotype carrying an FCGR3B
duplication derived from de novo assembly of fosmid
inserts tiling across the locus (Figure S5C).
The absence of nonpolymorphic PSVs in the 24.5 kb
region of paralogy together with the absence of chimeric
reads in sequence data derived from zero-copy individualserican Journal of Human Genetics 92, 28–40, January 10, 2013 33
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Figure 4. Organization of the FCGR2/
FCGR3 Locus in FCGR3B Copy-Number-
Variable Individuals
(A) Organization of the FCGR2/FCGR3
locus in an FCGR3B zero-copy individual
obtained by de novo assembly of sequence
capture data. The PSV alleles (see Figure 2)
confirm that the FCGR2B0 locus is
a chimera of 50 proximal sequence and 30
distal sequence.
(B) Organization of the FCGR2/FCGR3
locus in an individual with an FCGR3B
duplication obtained by de novo assembly
of fosmid clones. The organization of the
locus in both individuals with an FCGR3B
duplication and individuals with an
FCGR3B deletion suggests that the FCGR3B
CNV breakpoint is balanced.indicate that all breakpoints in our data set lie within the
24.5 kb regions of 100% paralogy between proximal and
distal region with proximal sequence running seamlessly
into identical distal sequence. The breakpoint can be
located anywhere between the PSVs flanking the PSV-free
24.5 kb block.
Given our evidence that the breakpoint in deleted and
duplicated haplotypes is symmetrical, we believe that
FCGR3B deletion is a balanced recombination event that
creates a chimeric FCGR2C/FCGR2B gene that we designate
FCGR2B0 (Figure 4A). FCGR2B0 consists of upstream
elements and a 50 coding region that derive from FCGR2C
and a 30 coding region that derives from FCGR2B. The
coding sequence of FCGR2B0 is therefore identical to
FCGR2B, but FCGR2B0 would be expected to be under the
control of 50 flanking sequence derived from FCGR2C.
Functional Analysis of FCGR2B0 Expression
FCGR2C transcripts have been reported in both NK cells
(CD56þ lymphocytes) and in B lymphocytes (CD19þ
lymphocytes), whereas FCGR2B transcripts are only
present in B lymphocytes.29,30 This tissue specificity led
us to postulate that because of the approximation of the
FCGR2C regulatory sequence with FCGR2B coding
sequence in FCGR2B0, FCGR2B0 expression would be
detectable in NK cells of individuals carrying an FCGR3B
zero-copy haplotype but would be undetectable in individ-
uals not carrying an FCGR3B zero-copy haplotype.
To test this hypothesis, we analyzed blood samples from
individuals with zero, one, and two copies (one on each
chromosome of the diploid genome) of FCGR3B by flow
cytometry employing anti-CD56 and anti-CD19 and the
specific anti-FcgRIIb antibody 2B6.31 Each sample con-
tained a CD19þ 2B6þ population (Figure 5A, top left,
center, and right plots), corresponding to B cells on which
FcgRIIb is present. Individuals with zero or one copy of
FCGR3B present two 2B6þ cell populations (2B6low and
2B6bright, Figure 5A, top center and right plots), whereas
those with two copies of FCGR3B, not carrying a deleted34 The American Journal of Human Genetics 92, 28–40, January 10, 2haplotype, show only one 2B6þ population, which
corresponds to 2B6bright (Figure 5A, top-left plot). The
detection of this 2B6low population suggested that there
might be ectopic FcgRIIb on cells that did not express
CD19. By using CD56 expression as a marker for NK
cells, we showed that those without an FCGR3B-deleted
haplotype (two-copy individuals) exhibited a negligible
(0.66%) proportion of CD56þ 2B6þ cells as expected
(Figure 5A, bottom-left plot). In marked contrast, a signifi-
cant proportion (>70%) of CD56þ cells from individuals
with zero or one copy of FCGR3B, bearing a deleted
haplotype (Figure 5A, bottom-center and -right plots)
showed expression of FCGR2B in their NK cells. Irrespec-
tive of FCGR3B CNV, all individuals show the two
CD56þ populations (CD56low andCD56bright, Figure 5A,
bottom-left, -centre and -right plots) described previ-
ously.32,33 In FCGR3B zero- and one-copy individuals, the
CD56low population is predominantly 2B6þ, which
demonstrates that the individuals who carry a deleted
FCGR3B haplotype translate FcgRIIb in this subset of NK
cells (Figure 5A, bottom-center and -right plots). These
CD56low cells produce low levels of NK-derived cytokines,
but they are potent mediators of antibody-dependent
cell mediated cytotoxicity (ADCC).32 In the samples
analyzed from individuals with zero-, one-, or two copies
of FCGR3B, in >95% of CD19þ cells FcgRIIb is detected.
Similar proportions, 67% and 74%, respectively, of
CD56þ (NK) cells from individuals who carry an
FCGR3B-deleted haplotype (FCGR3B one- and zero-copy)
translate FcgRIIb (Figure 5B). A comparison between the
mean fluorescence of 2B6 in B and NK cells shows that
accumulation of FcgRIIb is approximately 8-fold higher
in B cells than in NK cells in zero- and one-copy FCGR3B
individuals (Table S3). There is no statistically significant
difference (independent samples Kruskal-Wallis test signif-
icance: 0.117) in the magnitude of FcgRIIb accumulation
on B cells between unrelated zero-copy, one-copy, and
two-copy donors, although we acknowledge that the
cohort size is small.013
Figure 5. Flow Cytometry Analysis of
FcgRIIb Accumulation in B and NK
Lymphocytes in Relation to FCGR3B Copy
Number
(A) FcgRIIb accumulation in B andNK cells
of individuals with different FCGR3B copy
number. The top plots show accumulation
of FcgRIIb (2B6þ) in B cells (CD19þ) of
FCGR3B two-copy (not carrying an
FCGR3B-deleted haplotype), one-copy
(carrying one deleted haplotype) and
zero-copy (carrying two deleted haplo-
types) individuals, respectively. The two
2B6þ populations (2B6low, 2B6bright)
are indicated. The bottom plots show accu-
mulation of FcgRIIb (2B6þ) in NK cells
(CD56þ) of FCGR3B two-, one-, and zero-
copy individuals. The two populations of
CD56þ (CD56low, CD56bright) and
2B6þ (2B6low, 2B6bright) are indicated.
The seemingly more pronounced CD56þ
2B6þ signal in one-copy individuals
compared to zero-copy individuals is
a result of the difference in the total cell
count in the two samples. The quantitative
flow cytometry data (Table S3) summa-
rized in (B) shows that the percentages of
NK cells on which FcgRIIb is detected
(2B6þ) are similar in one- and zero-copy
individuals.
(B) Relative frequency of B and NK cells on
which FcgRIIb is detected (2B6þ) in indi-
viduals with different FCGR3B copy
number. Shown is the mean percentage
of CD19þ (B) and CD56þ (NK) cells on
which FcgRIIb is detected (2B6þ) in
FCGR3B two-, one-, and zero-copy individ-
uals, respectively. The number of individ-
uals n analyzed is given below each plot.
Whiskers indicate SD.Immunoblotting of B and NK cell preparations with
a second antibody specific to an intracellular FcgRIIb
C-terminal epitope (C-20) confirms the ectopic presence
on NK cells from individuals with a deleted FCGR3B haplo-
type and corroborates the flow cytometry data obtained
with the 2B6 antibody (Figure 6).Haplotypic Origin of Ectopic FcgRIIb
We designed a reverse transcription (RT)-PCR assay to
characterize the FcgRIIb-encoding transcripts present in
NK cells in an individual carrying a deleted FCGR3B
haplotype and also heterozygous for the FGCR2B-I232T
SNP rs1050501 (Figure 7A), enabling measurement of
the allelic expression of FCGR2B from the two parental
chromosomes. We isolated RNA from highly purified
(>95%) B and NK cell preparations from the same indi-
vidual and sequenced the cDNA. The presence of two
peaks at the SNP site in the transcript sequence from puri-
fied B cells (Figure 7B) is evidence that the transcript is
generated from both alleles. The presence of only one
peak in the sequence from NK cells (Figure 7C) indicates
that the transcript is produced only from one allele and
that the ectopically expressed FCGR2B RNA (and thereforeThe Amprotein) originates from the FCGR2B0 gene on the zero-
copy haplotype.Discussion
Intensive genetic analysis of SLE over several decades,
including a number of recent genome-wide association
studies, has revealed more than 30 robust susceptibility
loci for the disease.34 Studies in rodent models of SLE
have also yielded insights, with clear evidence that Fc
gamma receptors have an influence on SLE susceptibility
phenotypes.35 Amongst these, the finding of Fcgr3 copy-
number variation in rats and humans led to replicated
reports of association between FCGR3B copy-number vari-
ation and SLE in humans.4,7,14,18,36
The studies presented here aim to understand in
more depth the relationship between FCGR3B copy-
number variation and susceptibility to SLE. We identify
and designate a chimeric gene, FCGR2B0, that occurs as
a consequence of FCGR3B deletion on FCGR3B zero-copy
haplotypes, that (1) is defined by the juxtaposition of the
regulatory region of FCGR2C and the coding region of
FCGR2B, (2) is expressed ectopically in NK cells, anderican Journal of Human Genetics 92, 28–40, January 10, 2013 35
Figure 7. Sequence Analysis of FCGR2B Transcripts Present in
NK Cells of a an FCGR3B One-Copy Individual
FCGR2B sequence around SNP rs1050501 (arrow) amplified from
(A) genomic DNA, (B) mRNA isolated from purified B cells, (C)
mRNA isolated from purified NK cells.
Figure 6. Protein Immunoblot Analysis of FcgRIIb Accumulation
in B and NK Lymphocytes in Relation to the FCGR3B Copy
Number
FcgRIIb was detected with a goat polyclonal antibody (CD32B
[C-20]) (left panel). Anti-b actin was used for quantification
(right panel).(3) provides a previously unexpected explanation for the
mechanism underlying association of low FCGR3B copy
number and susceptibility to SLE.
We carried out extensive sequence analysis of the
FCGR2/FCGR3 locus to establish the extent of interindi-
vidual variation in FCGR2/FCGR3 haplotype structure
and the location of breakpoints leading to FCGR3B copy-
number variation. The high segmental sequence similarity
found across the FCGR locus makes the study of the
genomic pathology of FCGR3B CNV particularly chal-
lenging. By using a combination of in silico analyses and
high-throughput sequencing of fosmid clones, we identi-
fied a set of informative PSVs that allowed us to narrow
the potential breakpoint region to a 24.5 kb region of paral-
ogy between the two ancestral duplicated blocks. However,
the complete absence of nonpolymorphic PSVs in the 24.5
kb region prevented more precise localization of break-
points in FCGR3B-deleted or FCGR3B-duplicated haplo-
types. The absence of nonpolymorphic PSVs across the
duplicated 24.5 kb region makes it likely that the break-
point region cannot be narrowed down any further with
current sequencing technologies.
A recent study reported mapping of FCGR3B CNV break-
points based on PSVs identified from alignment of the
reference sequence of the proximal and distal blocks,
assuming that the vast majority of differences between
the two blocks are true PSVs.13 Our fosmid sequencing,
however, shows that 36% of candidate PSVs identified by
sequence alignment are subject to allelic variation, invalid-
ating their use as unambiguous PSVs, which is likely to
have compromised the breakpoint analysis presented in
that report. Our fosmid analysis also showed evidence of
swapping of sequence haplotypes between the proximal
and distal ancestral blocks in the duplicated 24.5 kb region
of near identity. The haplotype swapping that we observe
strongly supports the hypothesis that FCGR3B CNV break-
points most likely reside within the two 24.5 kb regions of
near identity in the proximal and distal blocks.
An illustrative schema of the proposed mechanism
through which swapping of haplotype sequences between
distal and proximal blocks could occur is shown in Figure 8.
Continuous ancestral shuffling of proximal and distal36 The American Journal of Human Genetics 92, 28–40, January 10, 2sequence by nonallelic homologous recombination that
resulted in a homogenization of paralogous sequence
variation across the region would explain why every PSV
position in the two 24.5 kb regions is also a SNP position.
Recurrent recombination has been proposed previously as
a mechanism leading to the homogenization of long
stretches of homologous sequence and as a confounding
factor in breakpoint analyses.37 The absence of PSVs as
well as the observed phenomenon of haplotype swapping
between proximal and distal regions gives reason to specu-
late that a defined breakpoint does not exist but that
recombination can take place across the duplicated 24.5
kb region. This, together with the observation of different
swapping patterns in the analyzed individuals suggests
that FCGR3-deleted haplotypes have not originated from
a single ancestral recombination event (identity by
descent) but have arisen on multiple occasions through
recurrent recombinations (identity by state).
By using the obtained PSV information, we showed that
in FCGR3B zero-copy haplotypes, the regulatory sequence
located upstream of FCGR2C and the coding sequence of
FCGR2B are juxtaposed as a consequence of the deletion
of FCGR3B. Thus the deletion of FCGR3B may be consid-
ered as a mechanism that generates a hybrid FCGR2C/
FCGR2B gene that we designate FCGR2B0 because its
coding sequence is indistinguishable from that of FCGR2B.
On account of the different tissue distribution for the
expression of FCGR2B and FCGR2C, we sought evidence
of aberrant expression of FCGR2B transcripts that arose
from FCGR2B0 on zero-copy haplotypes. We showed that
in individuals with FCGR3B-deleted haplotypes, FcgRIIb
is present on NK cells. Furthermore, we showed that in
an individual with a single FCGR3B-deleted haplotype,
the NK cell FCGR2B expression was derived from a single
chromosome.
The presence of FcgRIIb on B cells does not appear to be
affected by the deletion indicating that FCGR2C upstream013
A B C
Figure 8. Proposed Mechanism of Proximal and Distal Haplotype Swapping within the FCGR2C/FCGR3B/FCGR2B CNV Breakpoint
Region
Scenario of sequential recombination events between FCGR3B normal copy, duplicated and deleted haplotypes occurring at different
positions across the CNV breakpoint region that could explain swapping of sequence between proximal and distal region of the locus.
Numbers to the left of the haplotypes indicate FCGR3B copy number. (A) Nonhomologous recombination between FCGR2C and
FCGR2B, occurring between the two haplotype blocks bordering the 24.5 kb PSV-free regions, results in (B) a deleted and a duplicated
FCGR3B locus and a juxtaposition of proximal and distal haplotype blocks in the breakpoint region. The resulting FCGR2B0 and FCGR2C0
loci are in fact FCGR2C/FCGR2B and FCGR2B/FCGR2C chimera, respectively. However, as a result of the high sequence similarity across
the breakpoint region, these chimeric genes are indistinguishable from the bona fide FGCR2B and FCGR2C genes.
(C) Subsequent recombination with an FCGR3B normal copy locus occurring at the 50 end of the breakpoint region results in loci with
proximal sequence swapped to the distal region and vice versa.regulatory regions are sufficient for expression in both B
and NK cells. Despite the high identity between the near
upstream regions of FCGR2C and FCGR2B, it is likely that
there is a PSV (or a set of PSVs) between these two loci
that confers expression in NK cells. Its identification will
be of considerable value in future research that aims to
target expression to this cell type. In this sense, the PSV
analysis shows candidate regions that could alter the
expression within lymphocyte subsets.
The genomic data directly implicate both FCGR3B and
FCGR2C in the genomic perturbation caused by copy-
number polymorphism at this locus and this may throw
new light on the mechanisms by which deletion at this
locus increases the risk of SLE and RA. It is unlikely that
the loss of FCGR2C exerts a major impact on SLE risk
because the FCGR2C SNP rs10917661 (p.Gln57*) in exon
three produces a stop codon in themajority of alleles, trun-
cating the protein product in the healthy population, and
no association between this SNP and SLE has been
observed.38 We7 and others14 have shown that the reduced
FCGR3B copy number correlates with reduced protein
accumulation and FcgRIIIb function on neutrophils, and
reduced expression in neutrophils has been shown to
impair IgG-mediated opsonization.39 Studies using trans-
genic mice suggest that neutrophil FcgRIIIb may mediate
a less inflammatory effect on immune complex binding
compared with FcgRIIa.40 However, the importance of
the role of the neutrophil in immune complex clearance
is not clear. This prompted us to consider alternative,
possibly additional mechanisms, by which copy-number
polymorphism at the FCGR locus might impact on
immune function.
The role of NK cells in autoimmunity is not fully
understood. However, there is an increasing body of litera-The Amture, dating back more than 30 years, demonstrating
clearly that NK cell function is impaired in SLE41–43 and
RA:44,45 this includes reduced NK cell numbers as well as
NK cell mediated cytotoxicity. The predominant Fc
receptor that mediates cytotoxicity on NK cells is FcgRIIIa.
This receptor exhibits common polymorphism, and the
lower functioning 158F allele of FCGR3A shows an inde-
pendent genetic association with increased SLE risk.46
Ectopic presence of FcgRIIb on NK cells may inhibit the
function of other Fc receptors, particularly FcgRIIIa,
because the two receptors are likely to colocalize on the
cell surface in lipid rafts.17,47 Our data indicate that the
ectopic expression is most marked in CD56dim NK cells,
a subset that is implicated in antibody-dependent cytotox-
icity. Thus, we speculate that the ectopic presence of
FcgRIIb contributes to impaired NK cell cytotoxic func-
tion. This hypothesis is given further support by the
observation made by two groups33,48 that a subset of NK
cells could express FCGR2B. The NK cells expressing
FCGR2B were shown to exhibit weaker antibody-depen-
dent degranulation, which could be reversed on blocking
FcgRIIb. These data indicate that FcgRIIb on NK cells exerts
an inhibitory effect on NK cell function. Recently, NK cells
(specifically CD56dim NK cells) have been shown to
promote interferon-alpha production by plasmacytoid
dendritic cells: a capacity that is impaired in NK cells
from SLE patients.49 This is an alternative SLE-associated
NK cell function alteration to which ectopic FcgRIIb might
contribute.
Our data point to an additive mechanism for predisposi-
tion to SLE in people with zero or one copy of FCGR3B:
reduced CNV at the FCGR locus, in addition to remov-
ing FCGR3B, also generates a hybrid FCGR2C/FCGR2B
gene (FCGR2B0) leading to functional, ectopic presence oferican Journal of Human Genetics 92, 28–40, January 10, 2013 37
the only inhibitory FcgR. Both of these effects may
contribute additively to SLE risk, with reduction of
FcgRIIIb levels on neutrophils decreasing Ig binding and
clearance of immune complexes and appearance of
FcgRIIb on NK cells, which in turn inhibits the activity
of these cells. Impaired NK cell function is recognized
as a characteristic immunological feature of SLE. Our
data suggest that CNV at a given locus may exert multiple
functional effects such as gene dosage effects and aberrant
regulation of transcription, important factors when
exploring the relationship between CNV and associated
phenotypes.Supplemental Data
Supplemental Data includes five figures, three tables, and Supple-
mental Experimental Procedures and can be found with this
article online at http://dx.doi.org/10.1016/j.ajhg.2012.11.013.Acknowledgements
We acknowledge support from theWellcome Trust to H.T.C., T.J.V.
and T.J.A., from the MRC to T.J.A., and from the Imperial NIHR-
funded Biomedical Research Centre to T.J.A. and T.J.V.
Received: August 3, 2012
Revised: September 12, 2012
Accepted: November 26, 2012
Published: December 20, 2012Web Resources
The URLs for data presented herein are as follows:
Online Mendelian Inheritance in Man (OMIM), http://www.
omim.org/
UCSC Genome Browser, http://genome.ucsc.edu
NCBI Trace Archive, http://www.ncbi.nlm.nih.gov/Traces/home
Human Genome Structural Variation Project, http://hgsv.
washington.edu
Fosmid-clone-ID-to-NCBI-trace-name mapping, http://hgsv.
washington.edu/general/download/clone_mapping/
The URLs scripts and software tools that were obtained are as
follows:
untag command line tool, http://bioinf.eva.mpg.de/pts
sff_extract command line tool, http://bioinf.comav.upv.es/sff_
extract
query_tracedb Perl script, ftp://ftp.ncbi.nih.gov/pub/TraceDB/
misc/query_tracedb
BLAT software package, http://hgwdev.cse.ucsc.edu/~kent/src/
blatSrc34.zip
CNV-seqRpackage,http://tiger.dbs.nus.edu.sg/cnv-seq/cnv-seq.tar.gzAccession Numbers
The fosmid clone sequence data reported in this paper have been
deposited at the European Nucleotide Archive, which is hosted at
the European Bioinformatics Institute, under accession number
ERP001881. The sequence capture data has been deposited at38 The American Journal of Human Genetics 92, 28–40, January 10, 2the European Genome-Phenome Archive, which is hosted at the
European Bioinformatics Institute, under accession number
EGAS00001000376. The Genbank accession numbers for the
hydatidiform mole BAC clone sequences reported in this paper
are AC243898, AC243440, AC243509, AC243424, AC243499.References
1. Deng, Y., and Tsao, B.P. (2010). Genetic susceptibility to
systemic lupus erythematosus in the genomic era. Nat Rev
Rheumatol 6, 683–692.
2. Mun˜oz, L.E., Lauber, K., Schiller, M., Manfredi, A.A., and
Herrmann, M. (2010). The role of defective clearance of
apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol
6, 280–289.
3. Johnson, A.E., Gordon, C., Palmer, R.G., and Bacon, P.A.
(1995). The prevalence and incidence of systemic lupus
erythematosus in Birmingham, England. Relationship to
ethnicity and country of birth. Arthritis Rheum. 38,
551–558.
4. Aitman, T.J., Dong, R., Vyse, T.J., Norsworthy, P.J., Johnson,
M.D., Smith, J., Mangion, J., Roberton-Lowe, C., Marshall,
A.J., Petretto, E., et al. (2006). Copy number polymorphism
in Fcgr3 predisposes to glomerulonephritis in rats and
humans. Nature 439, 851–855.
5. Fanciulli, M., Vyse, T.J., and Aitman, T.J. (2008). Copy number
variation of Fc gamma receptor genes and disease predisposi-
tion. Cytogenet. Genome Res. 123, 161–168.
6. Willcocks, L.C., Smith, K.G.C., and Clatworthy, M.R. (2009).
Low-affinity Fcgamma receptors, autoimmunity and infec-
tion. Expert Rev. Mol. Med. 11, e24.
7. Morris, D.L., Roberts, A.L.,Witherden, A.S., Tarzi, R., Barros, P.,
Whittaker, J.C., Cook, T.H., Aitman, T.J., and Vyse, T.J. (2010).
Evidence for both copy number and allelic (NA1/NA2) risk at
the FCGR3B locus in systemic lupus erythematosus. Eur. J.
Hum. Genet. 18, 1027–1031.
8. McKinney, C., Fanciulli, M., Merriman, M.E., Phipps-Green,
A., Alizadeh, B.Z., Koeleman, B.P.C., Dalbeth, N., Gow, P.J.,
Harrison, A.A., Highton, J., et al. (2010). Association of varia-
tion in Fcgamma receptor 3B gene copy number with rheuma-
toid arthritis in Caucasian samples. Ann. Rheum. Dis. 69,
1711–1716.
9. Robinson, J.I., Carr, I.M., Cooper, D.L., Rashid, L.H., Martin,
S.G., Emery, P., Isaacs, J.D., Barton, A., Wilson, A.G., Barrett,
J.H., and Morgan, A.W.; BRAGGSS. (2012). Confirmation of
association of FCGR3B but not FCGR3A copy number with
susceptibility to autoantibody positive rheumatoid arthritis.
Hum. Mutat. 33, 741–749.
10. Ravetch, J.V., and Lanier, L.L. (2000). Immune inhibitory
receptors. Science 290, 84–89.
11. Warmerdam, P.A., Nabben, N.M., van de Graaf, S.A., van de
Winkel, J.G., and Capel, P.J. (1993). The human low affinity
immunoglobulin G Fc receptor IIC gene is a result of an
unequal crossover event. J. Biol. Chem. 268, 7346–7349.
12. Breunis, W.B., van Mirre, E., Geissler, J., Laddach, N., Wol-
bink, G., van der Schoot, E., de Haas, M., de Boer, M., Roos,
D., and Kuijpers, T.W. (2009). Copy number variation at
the FCGR locus includes FCGR3A, FCGR2C and FCGR3B
but not FCGR2A and FCGR2B. Hum. Mutat. 30, E640–
E650.
13. Machado, L.R., Hardwick, R.J., Bowdrey, J., Bogle, H., Knowles,
T.J., Sironi, M., and Hollox, E.J. (2012). Evolutionary history of013
copy-number-variable locus for the low-affinity Fcg receptor:
mutation rate, autoimmune disease, and the legacy of
helminth infection. Am. J. Hum. Genet. 90, 973–985.
14. Willcocks, L.C., Lyons, P.A., Clatworthy, M.R., Robinson, J.I.,
Yang, W., Newland, S.A., Plagnol, V., McGovern, N.N.,
Condliffe, A.M., Chilvers, E.R., et al. (2008). Copy number
of FCGR3B, which is associatedwith systemic lupus erythema-
tosus, correlates with protein expression and immune
complex uptake. J. Exp. Med. 205, 1573–1582.
15. Nagarajan, S., Chesla, S., Cobern, L., Anderson, P., Zhu, C.,
and Selvaraj, P. (1995). Ligand binding and phagocytosis by
CD16 (Fc gamma receptor III) isoforms. Phagocytic signaling
by associated zeta and gamma subunits in Chinese hamster
ovary cells. J. Biol. Chem. 270, 25762–25770.
16. Kono, H., Kyogoku, C., Suzuki, T., Tsuchiya, N., Honda, H.,
Yamamoto, K., Tokunaga, K., and Honda, Z.-I. (2005). Fcgam-
maRIIB Ile232Thr transmembrane polymorphism associated
with human systemic lupus erythematosus decreases affinity
to lipid rafts and attenuates inhibitory effects on B cell
receptor signaling. Hum. Mol. Genet. 14, 2881–2892.
17. Floto, R.A., Clatworthy, M.R., Heilbronn, K.R., Rosner, D.R.,
MacAry, P.A., Rankin, A., Lehner, P.J., Ouwehand,W.H., Allen,
J.M., Watkins, N.A., and Smith, K.G. (2005). Loss of function
of a lupus-associated FcgammaRIIb polymorphism through
exclusion from lipid rafts. Nat. Med. 11, 1056–1058.
18. Niederer, H.A., Willcocks, L.C., Rayner, T.F., Yang, W., Lau,
Y.L., Williams, T.N., Scott, J.A.G., Urban, B.C., Peshu, N., Dun-
stan, S.J., et al. (2010). Copy number, linkage disequilibrium
and disease association in the FCGR locus. Hum. Mol. Genet.
19, 3282–3294.
19. Su, K., Yang, H., Li, X., Li, X., Gibson, A.W., Cafardi, J.M.,
Zhou, T., Edberg, J.C., and Kimberly, R.P. (2007). Expression
profile of FcgammaRIIb on leukocytes and its dysregulation
in systemic lupus erythematosus. J. Immunol. 178, 3272–
3280.
20. Kidd, J.M., Cooper, G.M., Donahue, W.F., Hayden, H.S., Sam-
pas, N., Graves, T., Hansen, N., Teague, B., Alkan, C., Anto-
nacci, F., et al. (2008). Mapping and sequencing of structural
variation from eight human genomes. Nature 453, 56–64.
21. Kidd, J.M., Cheng, Z., Graves, T., Fulton, B., Wilson, R.K., and
Eichler, E.E. (2008). Haplotype sorting using human fosmid
clone end-sequence pairs. Genome Res. 18, 2016–2023.
22. Meyer, M., Stenzel, U., and Hofreiter, M. (2008). Parallel
tagged sequencing on the 454 platform. Nat. Protoc. 3,
267–278.
23. Kent, W.J. (2002). BLAT—the BLAST-like alignment tool.
Genome Res. 12, 656–664.
24. Li, H., and Durbin, R. (2009). Fast and accurate short read
alignment with Burrows-Wheeler transform. Bioinformatics
25, 1754–1760.
25. Li, H., and Durbin, R. (2010). Fast and accurate long-read
alignment with Burrows-Wheeler transform. Bioinformatics
26, 589–595.
26. Xie, C., and Tammi, M.T. (2009). CNV-seq, a new method to
detect copy number variation using high-throughput
sequencing. BMC Bioinformatics 10, 80.
27. Hollox, E.J., Detering, J.-C., and Dehnugara, T. (2009). An
integrated approach for measuring copy number variation at
the FCGR3 (CD16) locus. Hum. Mutat. 30, 477–484.
28. Antonacci, F., Kidd, J.M., Marques-Bonet, T., Teague, B.,
Ventura, M., Girirajan, S., Alkan, C., Campbell, C.D., Vives,
L., Malig, M., et al. (2010). A large and complex structuralThe Ampolymorphism at 16p12.1 underlies microdeletion disease
risk. Nat. Genet. 42, 745–750.
29. Cassel, D.L., Keller, M.A., Surrey, S., Schwartz, E., Schreiber,
A.D., Rappaport, E.F., and McKenzie, S.E. (1993). Differential
expression of Fc gamma RIIA, Fc gamma RIIB and Fc gamma
RIIC in hematopoietic cells: analysis of transcripts. Mol. Im-
munol. 30, 451–460.
30. Metes, D., Ernst, L.K., Chambers, W.H., Sulica, A., Herberman,
R.B., and Morel, P.A. (1998). Expression of functional CD32
molecules on humanNK cells is determined by an allelic poly-
morphism of the FcgammaRIIC gene. Blood 91, 2369–2380.
31. Veri, M.-C., Gorlatov, S., Li, H., Burke, S., Johnson, S., Staven-
hagen, J., Stein, K.E., Bonvini, E., and Koenig, S. (2007).
Monoclonal antibodies capable of discriminating the human
inhibitory Fcgamma-receptor IIB (CD32B) from the activating
Fcgamma-receptor IIA (CD32A): biochemical, biological and
functional characterization. Immunology 121, 392–404.
32. Cooper, M.A., Fehniger, T.A., Turner, S.C., Chen, K.S., Gha-
heri, B.A., Ghayur, T., Carson, W.E., and Caligiuri, M.A.
(2001). Human natural killer cells: a unique innate immuno-
regulatory role for the CD56(bright) subset. Blood 97, 3146–
3151.
33. Dutertre, C.-A., Bonnin-Ge´lize´, E., Pulford, K., Bourel, D., Frid-
man, W.-H., and Teillaud, J.-L. (2008). A novel subset of NK
cells expressing high levels of inhibitory FcgammaRIIB modu-
lating antibody-dependent function. J. Leukoc. Biol. 84,
1511–1520.
34. Hindorff, L., MacArthur, J., Wise, A., Junkins, H., Hall, P.,
Klemm, K., and Manolio, T. (2012). A Catalog of Published
Genome-Wide Association Studies, http://www.genome.gov/
gwastudies.
35. Lin, Q., Xiu, Y., Jiang, Y., Tsurui, H., Nakamura, K., Kodera, S.,
Ohtsuji, M., Ohtsuji, N., Shiroiwa, W., Tsukamoto, K., et al.
(2006). Genetic dissection of the effects of stimulatory and
inhibitory IgG Fc receptors on murine lupus. J. Immunol.
177, 1646–1654.
36. Fanciulli, M., Norsworthy, P.J., Petretto, E., Dong, R., Harper,
L., Kamesh, L., Heward, J.M., Gough, S.C.L., de Smith, A., Bla-
kemore, A.I.F., et al. (2007). FCGR3B copy number variation is
associated with susceptibility to systemic, but not organ-
specific, autoimmunity. Nat. Genet. 39, 721–723.
37. Blanco, P., Shlumukova, M., Sargent, C.A., Jobling, M.A., Af-
fara, N., and Hurles, M.E. (2000). Divergent outcomes of intra-
chromosomal recombination on the human Y chromosome:
male infertility and recurrent polymorphism. J. Med. Genet.
37, 752–758.
38. Su, K., Wu, J., Edberg, J.C., McKenzie, S.E., and Kimberly, R.P.
(2002). Genomic organization of classical human low-
affinity Fcgamma receptor genes. Genes Immun. 3(Suppl 1 ),
S51–S56.
39. Fossati, G., Moots, R.J., Bucknall, R.C., and Edwards, S.W.
(2002). Differential role of neutrophil Fcgamma receptor IIIB
(CD16) in phagocytosis, bacterial killing, and responses to
immune complexes. Arthritis Rheum. 46, 1351–1361.
40. Tsuboi, N., Asano, K., Lauterbach, M., and Mayadas, T.N.
(2008). Human neutrophil Fcgamma receptors initiate and
play specialized nonredundant roles in antibody-mediated
inflammatory diseases. Immunity 28, 833–846.
41. Tsokos, G.C., Rook, A.H., Djeu, J.Y., and Balow, J.E. (1982).
Natural killer cells and interferon responses in patients with
systemic lupus erythematosus. Clin. Exp. Immunol. 50,
239–245.erican Journal of Human Genetics 92, 28–40, January 10, 2013 39
42. Green, M.R.J., Kennell, A.S.M., Larche, M.J., Seifert, M.H.,
Isenberg, D.A., and Salaman, M.R. (2005). Natural killer cell
activity in families of patients with systemic lupus erythema-
tosus: demonstration of a killing defect in patients. Clin. Exp.
Immunol. 141, 165–173.
43. Park, Y.-W., Kee, S.-J., Cho, Y.-N., Lee, E.-H., Lee, H.-Y., Kim,
E.-M., Shin, M.-H., Park, J.-J., Kim, T.-J., Lee, S.-S., et al.
(2009). Impaired differentiation and cytotoxicity of natural
killer cells in systemic lupus erythematosus. Arthritis Rheum.
60, 1753–1763.
44. Hendrich, C., Kuipers, J.G., Kolanus, W., Hammer, M., and
Schmidt, R.E. (1991). Activation of CD16þ effector cells by
rheumatoid factor complex. Role of natural killer cells in rheu-
matoid arthritis. Arthritis Rheum. 34, 423–431.
45. Conigliaro, P., Scrivo, R., Valesini, G., and Perricone, R. (2011).
Emerging role for NK cells in the pathogenesis of inflamma-
tory arthropathies. Autoimmun. Rev. 10, 577–581.
46. Wu, J., Edberg, J.C., Redecha, P.B., Bansal, V., Guyre, P.M., Co-
leman, K., Salmon, J.E., and Kimberly, R.P. (1997). A novel40 The American Journal of Human Genetics 92, 28–40, January 10, 2polymorphism of FcgammaRIIIa (CD16) alters receptor func-
tion and predisposes to autoimmune disease. J. Clin. Invest.
100, 1059–1070.
47. Kondadasula, S.V., Roda, J.M., Parihar, R., Yu, J., Lehman, A.,
Caligiuri, M.A., Tridandapani, S., Burry, R.W., and Carson,
W.E., 3rd (2008). Colocalization of the IL-12 receptor and
FcgammaRIIIa to natural killer cell lipid rafts leads to activa-
tion of ERK and enhanced production of interferon-gamma.
Blood 111, 4173–4183.
48. van der Heijden, J., Breunis, W.B., Geissler, J., de Boer, M., van
den Berg, T.K., and Kuijpers, T.W. (2012). Phenotypic variation
in IgG receptors by nonclassical FCGR2C alleles. J. Immunol.
188, 1318–1324.
49. Hagberg, N., Berggren, O., Leonard, D., Weber, G., Bryceson,
Y.T., Alm, G.V., Eloranta, M.-L., and Ro¨nnblom, L. (2011).
IFN-a production by plasmacytoid dendritic cells stimulated
with RNA-containing immune complexes is promoted
by NK cells via MIP-1b and LFA-1. J. Immunol. 186, 5085–
5094.013
